🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1, randomised, open-label, three-way, three-period, crossov...
Status
Active Not Recruiting
Location
Fuzhou University Affiliated Provincial Hospital
Start Date
2026-06-08
Trial ID
NCT07610148
Treatments Being Tested
This study aims to evaluate the safety, tolerability, efficacy and pharmaco...
Status
Recruiting
Location
The Second Affiliated Hospital of Dalian Medical University
Start Date
2026-03-27
Trial ID
NCT07389733
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
The study is being conducted to evaluate the safety, PK and efficacy of HRS...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-08-12
Trial ID
NCT06555068
Treatments Being Tested
To evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-...
Status
Recruiting
Location
Southern Highlands Private Hospital
Start Date
2026-05-15
Trial ID
NCT07358377
Treatments Being Tested
The study is being conducted to evaluate the efficacy, andsafety of HRS-620...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center-
Start Date
2023-03-23
Trial ID
NCT05781048
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of dexmed...
Status
Recruiting
Location
Harbin Medical University Affiliated Cancer Hospital
Start Date
2025-01-21
Trial ID
NCT06679036
This is a study to evaluate the safety, tolerability, and pharmacokinetic c...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2025-05-22
Trial ID
NCT06974929
Treatments Being Tested